Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By IPO Scoop (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

The IPO Buzz: Exzeo (XZO Proposed) Sets Terms for $168 Million IPO

% of readers think this story is Fact. Add your two cents.


Exzeo Group (XZO Proposed), a P&C InsurTech platform company based in Tampa, Florida, set the terms for its IPO – 8 million shares at a price range of $20.00 to $22.00 – to raise $168 million, if priced at the $21.00 mid-point of its range, in its S-1/A filing early today (Thursday, Oct. 16, 2025). Under those terms, Exzeo Group would have a market cap of about $1.91 billion. This is a New York Stock Exchange listing.

The InsurTech platform company is going public via a carve-out from HCI Group, an NYSE-listed company that holds 90.69 percent of its stock before the IPO, according to the prospectus.

After the IPO, the HCI Group will still own about 75 million shares of Exzeo’s stock, which will represent about 81.54 percent of its total outstanding shares of common stock and voting power – if the underwriters’ option in this offering is exercised in full, the prospectus said.

Truist Securities is the leading book-runner with Citizens Capital Markets and William Blair as joint book-runners. Fifth Third Securities is the co-manager.

The IPO is expected to price during the first week of November.

Exzeo, founded in 2012, provides P&C (property and casualty insurance) carriers and their agents with insurance technology solutions through its Exzeo Platform, the prospectus said. The platform offers nine software and data analytics applications for functions that include insurance quotes and underwriting as well as claim management, data and analytics and other functions.

“Our insurance solutions support over $1.2 billion of premiums in force,” Exzeo said in the prospectus. “We serve customers in 13 states.”

Exzeo has insurance agency licenses or managing general agent licenses in 29 states, according to the prospectus.

The company is profitable, according to financial statements in the prospectus: Exzeo earned net income of $56.57 million on revenue of $182.14 million for the 12 months that ended on June 30, 2025.

(For more information about these companies, please check the IPO Calendar  and the individual IPO Profiles found on the IPOScoop.com  website.) 

Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board. 

To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message. 

Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.


Source: https://www.iposcoop.com/the-ipo-buzz-exzeo-xzo-proposed-sets-terms-for-168-million-ipo/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login